Aldeyra Therapeutics Inc. (ALDX)
NASDAQ · Healthcare
Aldeyra Therapeutics Inc. Cash on Hand 2020–2025
Aldeyra Therapeutics Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Aldeyra Therapeutics Inc. cash on hand as of December 31, 2025: 70.0M, a 28.45% increase year-over-year.
- Aldeyra Therapeutics Inc. cash on hand for 2025 were 70.0M, a 28.45% increase from 2024.
- Aldeyra Therapeutics Inc. cash on hand for 2024 were 54.5M, a 61.82% decrease from 2023.
- Aldeyra Therapeutics Inc. cash on hand for 2023 were 142.8M, a 1.11% decrease from 2022.
- Aldeyra Therapeutics Inc. cash on hand for 2022 were 144.4M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aldeyra Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $70 |
| 2024 | $55 |
| 2023 | $143 |
| 2022 | $144 |
| 2021 | $230 |
| 2020 | $78 |
Aldeyra Therapeutics Inc. Cash on Hand — FAQ
Aldeyra Therapeutics Inc. (ALDX) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALDX's cash on hand history?
The chart and table above show Aldeyra Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.